Annual EBIT
-$126.05 M
-$120.29 M-2090.23%
31 December 2023
Summary:
Marinus Pharmaceuticals annual earnings before interest & taxes is currently -$126.05 million, with the most recent change of -$120.29 million (-2090.23%) on 31 December 2023. During the last 3 years, it has fallen by -$29.85 million (-31.04%). MRNS annual EBIT is now -11487.42% below its all-time high of -$1.07 million.MRNS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$20.38 M
+$10.83 M+34.70%
30 September 2024
Summary:
Marinus Pharmaceuticals quarterly earnings before interest & taxes is currently -$20.38 million, with the most recent change of +$10.83 million (+34.70%) on 30 September 2024. Over the past year, it has increased by +$17.09 million (+45.61%). MRNS quarterly EBIT is now -126.24% below its all-time high of $77.68 million, reached on 30 September 2022.MRNS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$123.39 M
+$8.35 M+6.34%
30 September 2024
Summary:
Marinus Pharmaceuticals TTM earnings before interest & taxes is currently -$123.39 million, with the most recent change of +$8.35 million (+6.34%) on 30 September 2024. Over the past year, it has increased by +$2.66 million (+2.11%). MRNS TTM EBIT is now -13259.35% below its all-time high of -$923.60 thousand, reached on 31 March 2013.MRNS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +45.6% | +2.1% |
| 3 y3 years | -31.0% | +23.8% | -28.3% |
| 5 y5 years | -131.6% | -31.7% | -126.7% |
MRNS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2090.2% | at low | -126.2% | +45.6% | -3403.3% | +6.3% |
| 5 y | 5 years | -2090.2% | at low | -126.2% | +45.6% | -3403.3% | +6.3% |
| alltime | all time | <-9999.0% | at low | -126.2% | +45.6% | <-9999.0% | +6.3% |
Marinus Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.38 M(-34.7%) | -$123.39 M(-6.3%) |
| June 2024 | - | -$31.21 M(-9.1%) | -$131.74 M(+1.5%) |
| Mar 2024 | - | -$34.32 M(-8.4%) | -$129.79 M(+3.0%) |
| Dec 2023 | -$126.05 M(+2090.2%) | -$37.47 M(+30.4%) | -$126.05 M(+7.2%) |
| Sept 2023 | - | -$28.73 M(-1.8%) | -$117.56 M(+953.8%) |
| June 2023 | - | -$29.26 M(-4.3%) | -$11.16 M(-40.2%) |
| Mar 2023 | - | -$30.58 M(+5.5%) | -$18.67 M(+224.4%) |
| Dec 2022 | -$5.75 M(-94.0%) | -$28.98 M(-137.3%) | -$5.75 M(+63.4%) |
| Sept 2022 | - | $77.68 M(-311.2%) | -$3.52 M(-96.5%) |
| June 2022 | - | -$36.78 M(+108.1%) | -$100.03 M(+15.3%) |
| Mar 2022 | - | -$17.67 M(-34.0%) | -$86.72 M(-9.8%) |
| Dec 2021 | -$96.19 M(+42.6%) | -$26.75 M(+42.1%) | -$96.19 M(+10.7%) |
| Sept 2021 | - | -$18.83 M(-19.8%) | -$86.91 M(+3.8%) |
| June 2021 | - | -$23.47 M(-13.5%) | -$83.74 M(+10.3%) |
| Mar 2021 | - | -$27.14 M(+55.4%) | -$75.94 M(+12.2%) |
| Dec 2020 | -$67.47 M(+24.0%) | -$17.47 M(+11.6%) | -$67.66 M(+3.0%) |
| Sept 2020 | - | -$15.66 M(-0.1%) | -$65.66 M(+2.8%) |
| June 2020 | - | -$15.68 M(-16.9%) | -$63.90 M(+5.2%) |
| Mar 2020 | - | -$18.85 M(+21.9%) | -$60.74 M(+11.6%) |
| Dec 2019 | -$54.42 M(+46.4%) | -$15.47 M(+11.3%) | -$54.42 M(+10.6%) |
| Sept 2019 | - | -$13.90 M(+11.1%) | -$49.22 M(+5.8%) |
| June 2019 | - | -$12.51 M(-0.2%) | -$46.55 M(+6.7%) |
| Mar 2019 | - | -$12.54 M(+22.1%) | -$43.60 M(+17.3%) |
| Dec 2018 | -$37.18 M | -$10.27 M(-8.4%) | -$37.18 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$11.22 M(+17.3%) | -$31.64 M(+28.7%) |
| June 2018 | - | -$9.57 M(+56.5%) | -$24.59 M(+26.1%) |
| Mar 2018 | - | -$6.11 M(+29.0%) | -$19.50 M(+4.1%) |
| Dec 2017 | -$18.74 M(-33.5%) | -$4.74 M(+13.7%) | -$18.74 M(-5.9%) |
| Sept 2017 | - | -$4.17 M(-7.0%) | -$19.92 M(-9.9%) |
| June 2017 | - | -$4.48 M(-16.3%) | -$22.10 M(-16.4%) |
| Mar 2017 | - | -$5.35 M(-9.5%) | -$26.44 M(-6.2%) |
| Dec 2016 | -$28.18 M(+15.6%) | -$5.92 M(-6.8%) | -$28.18 M(-5.3%) |
| Sept 2016 | - | -$6.35 M(-28.1%) | -$29.75 M(+5.3%) |
| June 2016 | - | -$8.82 M(+24.4%) | -$28.25 M(+14.9%) |
| Mar 2016 | - | -$7.09 M(-5.3%) | -$24.58 M(+0.8%) |
| Dec 2015 | -$24.38 M(+127.5%) | -$7.49 M(+54.7%) | -$24.38 M(+19.3%) |
| Sept 2015 | - | -$4.84 M(-6.1%) | -$20.44 M(+18.6%) |
| June 2015 | - | -$5.16 M(-25.2%) | -$17.23 M(+12.1%) |
| Mar 2015 | - | -$6.89 M(+94.2%) | -$15.37 M(+37.9%) |
| Dec 2014 | -$10.72 M(+106.9%) | -$3.55 M(+116.5%) | -$11.15 M(+24.0%) |
| Sept 2014 | - | -$1.64 M(-50.2%) | -$8.99 M(+4.8%) |
| June 2014 | - | -$3.29 M(+23.6%) | -$8.58 M(+23.9%) |
| Mar 2014 | - | -$2.67 M(+91.1%) | -$6.92 M(+33.6%) |
| Dec 2013 | -$5.18 M(+376.1%) | -$1.39 M(+13.9%) | -$5.18 M(+36.8%) |
| Sept 2013 | - | -$1.22 M(-25.2%) | -$3.78 M(+47.8%) |
| June 2013 | - | -$1.64 M(+77.3%) | -$2.56 M(+177.3%) |
| Mar 2013 | - | -$923.60 K | -$923.60 K |
| Dec 2012 | -$1.09 M | - | - |
FAQ
- What is Marinus Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly EBIT year-on-year change?
- What is Marinus Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals TTM EBIT year-on-year change?
What is Marinus Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MRNS is -$126.05 M
What is the all time high annual EBIT for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.07 M
What is Marinus Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MRNS is -$20.38 M
What is the all time high quarterly EBIT for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly earnings before interest & taxes is $77.68 M
What is Marinus Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MRNS quarterly earnings before interest & taxes has changed by +$17.09 M (+45.61%)
What is Marinus Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MRNS is -$123.39 M
What is the all time high TTM EBIT for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high TTM earnings before interest & taxes is -$923.60 K
What is Marinus Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MRNS TTM earnings before interest & taxes has changed by +$2.66 M (+2.11%)